KTTA
Pasithea Therapeutics Corp.
-0.01 (-2.61%)0.48USD124K成交股數15.9M市值–本益比(近四季)32.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.7M | 2.9M | 2.7M | 1.4M | 2.1M | 1.7M | 1.6M | 2.4M | 1.7M | 3.4M | 1.6M | 2.0M |
| 銷售管理費用 | 2.0M | 1.9M | 7.5M | 1.8M | 1.7M | 2.0M | 1.4M | 1.6M | 2.3M | 1.8M | 2.2M | 1.8M |
| 營業利益 | −5.7M+50% | −4.9M+33% | −10.3M+241% | −3.1M-21% | −3.8M-6% | −3.7M-29% | −3.0M-21% | −3.9M+3% | −4.0M | −5.1M | −3.8M | −3.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.3M+42% | −2.9M-19% | −10.1M+237% | −3.0M-21% | −3.7M-4% | −3.6M-29% | −3.0M-17% | −3.9M+3% | −3.9M | −5.0M | −3.6M | −3.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.16-76% | -0.12-93% | -0.23-92% | -0.41-89% | -0.66-82% | -1.61+303% | -2.87 | -3.71+37000% | -3.70 | -0.40 | 0.00 | -0.01 |
| 稀釋股數 | 32.1M | 24.3M | 7.0M | 7.4M | 5.6M | 2.2M | 1.0M | 1.0M | 1.0M | 1.2M | 1.3M | 1.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 45.7M | 50.4M | 55.2M | 4.1M | 7.2M | 5.3M | 9.4M | 8.0M | 12.0M | 16.3M | 19.6M | 26.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 51.7M | 56.4M | 60.2M | 13.6M | 17.0M | 14.7M | 18.6M | 17.7M | 22.4M | 26.1M | 30.7M | 38.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.9M | 1.5M | 5.0M | 1.4M | 1.8M | 1.7M | 824K | 1.5M | 2.5M | 2.7M | 2.3M | 2.6M |
| 股東權益 | 49.8M | 54.8M | 55.2M | 12.2M | 15.2M | 13.0M | 17.8M | 16.2M | 19.9M | 23.4M | 28.4M | 35.6M |
| 負債比 | 3.6% | 2.7% | 8.3% | 10.4% | 10.8% | 11.5% | 4.4% | 8.4% | 11.3% | 10.4% | 7.4% | 6.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.8M+57% | – | – | – | −3.1M | – | – | −4.3M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | 24K | – | – | 5K | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 487K
| Clinics1 | 487K | 100.0% | +3130.4% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −20.4M | –% | -2.91 | – |
| FY2024 | – | – | −13.9M | –% | -12.69 | – |
| FY2023 | – | – | −16.0M | –% | -0.42 | −12.8M |
| FY2022 | 487K | +3130.4% | −13.9M | -2,864.3% | -1.76 | −14.7M |
| FY2021 | 15K | – | −2.2M | -14,430.5% | -0.21 | −3.2M |